Top Back to top

Physicians Webinars

Upcoming webinars from EBMT

More information coming soon!

          

Past webinars

  

How to transplant patients with Sickle Cell disease in 2021

The webinar was hosted by Dr Selim Corbacioglu and moderated by Dr Josu De La Fuente.

This recorded webinar will give you a step-by-step approach on how to approach hematopoietic stem cell transplantation and gene editing for sickle cell disease. It will highlight the pitfalls and particularities in the care of these utmost complicated patients as well as the specific transplant-related complications.

The video and slides are available for EBMT members on the e-learning platform.

 

Maintenance therapy after allogeneic SCT in AML

The live webinar was hosted by Dr Andreas Burchert and moderated by Dr Ali Barzabachi.

The learning objectives were:

  • What is the post HSCT standard of care and which patients are of high risk of relapse?
  • What is the available evidence to perform a post HSCT maintenance therapy in AML?
  • What types of treatments are available (targeted vs. non targeted)?
  • What is the achievable benefit vs. risks?
  • What is the future post HSCT maintenance treatment spectrum?

The video and slides are available for EBMT members on the e-learning platform.

Role of ATG/ATLG in stem cell transplantation

The live webinar was hosted by Dr Francesca Bonifazi and moderated by Dr Grzegorz Basak.

The learning objectives were:

  • Mandatoriness of GVHD prevention because of impact of GVHD on survival
  • Literature evidences on ATG/ATLG as GVHD prevention strategy
  • Mechanisms of action of ATG/ATLG
  • Quality of life after ATG/ATLG treatment
  • Open issues to increase outcome and knowledge about dosing and schedule

The video and slides are available for EBMT members on the e-learning platform.

Pre/post-transplant Bispecific Antibodies for ALL

The live webinar was hosted by Dr Christina Peters and moderated by Dr Franco Locatelli.

The learning objectives were:

  • to gain knowledge about biological aspects of Bispecific T-Cell Engager
  • to define dosing and infusion practice
  • to understand mechanisms of action and adverse reactions
  • to oversee clinical trials for adult and pediatric patients

The video and slides are available for EBMT members on the e-learning platform.

Role of MRD in stem cell transplantation for AML

The live webinar was hosted by Dr Michael Heuser.

The learning objectives were:

  • to know the indications where MRD may have a role for treatment decisions for AML
  • to know the prognostic role of MRD before and after alloHCT
  • to know how MRD may guide the transplant procedure
  • to be able to inform MRD-positive AML patients about post-transplant treatment strategies  
  • to be able to apply guideline recommendations for MRD

The video and slides are available for EBMT members on the e-learning platform.

Management of CMV infections after stem cell transplantation

The live webinar was hosted by Dr Per Ljungman.

The learning objectives were:

  • to understand the impact of CMV replication in allogeneic stem cell transplant recipients
  • to gain knowledge about antiviral drugs used for preventing and managing CMV
  • and, to recognize and manage patients with resistant/refractory CMV infection

The video and slides are available for EBMT members on the e-learning platform.

Selecting unrelated donor according to HLA and beyond

The live webinar was hosted by Dr Katharina Fleischhauer.

The learning objectives were:

  • to understand genetics and function of HLA and minor histocompatibility antigens
  • to get insights into methods and interpretation of HLA typing
  • to understand the role of allelic HLA locus mismatches different SCT donor settings
  • to oversee the principles of and models of functional matching
  • to review current recommendations for donor selection by HLA and beyond
  • and, to understand the impact of transplant practice on donor selection hierarchies

The video and slides are available for EBMT members on the e-learning platform.

Haploidentical transplants

The live webinar was hosted by Dr Andrea Bacigalupo.

The learning objectives were:

  • to describe the options for T cell repleted haploidentical SCT
  • to understand mode of action to prevent graft failure and GVHD
  • to define donor selection for T cell repleted haploidentical SCT
  • and, to describe outcome of T cell repleted haploidentical SCT in comparison to other donor sources

The video and slides are available for EBMT members on the e-learning platform.

Allogeneic stem cell transplantation for hemoglobinopathies

The live webinar was hosted by Dr Selim Corbaçioglu.

The learning objectives were:

  • to define indication for allogeneic stem cell transplantation in sickle cell anemia and thalassemia
  • to define major toxicity after allogeneic stem cell transplantation for hemoglobinopathies
  • to define the role of haploidentical stem cell transplantation
  • and, to define the role of gene therapy

The video and slides are available for EBMT members on the e-learning platform.

EBMT recommendations on clinical management of acute and chronic GVHD, novel therapeutic strategies in clinical development

The live webinar was hosted by Dr Olaf Penack.  

The learning objectives were:

  • to define current prophylaxis and treatment standards of acute and chronic GVHD
  • to define potential novel agents to prevent or treat acute and chronic GVHD
  • to define steroid refractory in acute and chronic GVHD
  • and, to define treatment options and results for steroid refractory acute and chronic GVHD

The video and slides are available for EBMT members on the e-learning platform.

Pathophysiology of acute and chronic GVHD, novel therapeutic strategies in pre-clinical phase

The live webinar was hosted by Dr Ernst Holler.

The learning objectives were:

  • to understand criteria and classification of acute and chronic GVHD
  • to understand biology and pathophysiology of acute and chronic GVHD 
  • and, to understand the role of microbiotics and the basis for further novel treatment options

The video and slides are available for EBMT members on the e-learning platform.

Past workshops

Statistical Course - 2021 Edition

Basic course in the use of statistical methods to analyse stem cell transplantation data.

It had two parts:

  1. Collection of data, simple comparative analyses. Speaker: Richard Szydlo.

The first session covered the following topics:

  • Best data collection practices using Excel and Access
  • Basic descriptive and comparative statistical methods using a live analysis of data (with SPSS)
  • Optimum methods for collecting data that require statistical analysis
  • A review of the most commonly used statistical methods to describe and compare groups
  1. Essential survival analysis methods. Speaker: Antonella Santucci. 

The second session covered the following topics:

  • Interval Time of follow-up and the status variable (censored/event observations)
  • How to collect data 
  • The survival function
  • Kaplan-Meier curves and the log rank test
  • An introduction to Cox proportional hazard model
  • Demonstrative exercises will be done by  using SPSS vers.25.
IMPORTANT INFORMATION:

One week before the event, all participants received access to on-demand content regarding theoretical information of “Essential survival analysis methods”. During the live event, more practical aspects were explained and there was time for questions and answers.

On-demand material and attendance certificate is available to consult for registered participants on the e-learning platform. 

Speakers:

  • Dr Richard Szydlo, Medical Statistician, Department of Haematology, Imperial College, London, UK.
  • Dr Antonella SantucciHaemathology Institut University of Study of Perugia.

EBMT Benchmarking: The What, How and When?

The EBMT Clinical Outcomes Group (COG) has developed the first phase of a bespoke risk-adapted international benchmarking model for one-year survival following allogeneic and autologous HSCT based on current capabilities within the EBMT registry core dataset. In November 2020, centres received the first data-completeness reports. This webinar will explain the origins and methodology of the model, the centre perspective and the next steps. The webinar will be an opportunity for users to address questions to the expert panel and to give feedback on this first report. This feedback will be taken into account for the next phase of this project.

Learning Objectives:
  • Understand the basis of the benchmarking model

  • Learn to interpret the data-completeness report

  • Hear of future plans for the model

Speaker panel:

Chair: 

  • Professor John Snowden, Consultant Haematologist and Director of BMT, Sheffield Teaching Hospitals NHS Foundation Trust & University of Sheffield, UK.

Speakers: 

  • Prof. Dr. Hein Putter. Biostatistician, Leiden University Medical Center, Leiden, The Netherlands.

  • Riccardo Saccardi, MD. Director, Cell Therapy and Transfusion Medicine Unit. Careggi University Hospital, Firenze, Italy.

  • Professor John Snowden, Consultant Haematologist and Director of BMT, Sheffield Teaching Hospitals NHS Foundation Trust & University of Sheffield, UK.

Q&A Section: 

  • Prof. Dr. Hein Putter. Biostatistician, Leiden University Medical Center, Leiden, The Netherlands.

  • Riccardo Saccardi, MD. Director, Cell Therapy and Transfusion Medicine Unit. Careggi University Hospital, Firenze, Italy.

  • Professor John Snowden, Consultant Haematologist and Director of BMT, Sheffield Teaching Hospitals NHS Foundation Trust & University of Sheffield, UK.
  • Dirk-Jan Eikema. Biostatistician specialized in survival analysis. EBMT.

  • Isabel Sánchez-Ortega. Medical Officer. EBMT

Statistical Course - 2020 Edition

Important information:

If you were registered to the workshop, you can access the material on the EBMT e-learning platform. Please, check your inbox/spam folder for the log-in information.

 

Basic course in the use of statistical methods to analyse stem cell transplantation data.
 
It had two parts,

  1. Collection of data, simple comparative analyses. Speaker: Richard Szydlo. From 12:00-14:00 CEST

The first session covered the following topics:

  • Best data collection practices using Excel and Access
  • Basic descriptive and comparative statistical methods using a live analysis of data (with SPSS)
  • Optimum methods for collecting data that require statistical analysis
  • A review of the most commonly used statistical methods to describe and compare groups
  1. Essential survival analysis methods. Speaker: Antonella Santucci. From 15:00-17:00 CEST

The second session covered the following topics:

  • Interval Time of follow-up and the status variable (censored/event observations)
  • How to collect data 
  • The survival function
  • Kaplan-Meier curves and the log rank test
  • An introduction to Cox proportional hazard model
  • Demonstrative exercises will be done by  using SPSS vers.25.

Speakers

Dr Richard Szydlo, Medical Statistician, Department of Haematology, Imperial College, London, UK.

Dr Antonella Santucci. Haemathology Institut University of Study of Perugia

Haploidentical family donors with special respect to minors as donor

This workshop was jointly organized by the EBMT Donor Outcome Committee and the WBMT.

The donor outcome committee of the EBMT together with the WBMT offered this workshop to raise awareness for haploidentical donors with a special focus on minors, serving as related donors for sibling or adult relatives. The workshop was focused on expert knowledge on haploidentical transplantation in children and adults, practical management of stem cell collection in minors and ethical considerations, and offered the participants the opportunity to interact with the speakers and discuss their current praxis. To reach these goals, the Faculty comprised a multidisciplinary team of experts in transplantations and in ethical questions.

Learning objective:
  • The aim of this virtual workshop was to discuss the current praxis and related ethical issues in haploidentical stem cell donation with a special focus on minors as donors. This workshop was intended to provide thoughts probably for preparation of an EBMT recommendations.
Speaker panel:

Coordinator:

  • Professor Nina Worel, Medical Director of the collection and processing facility, Department of Transfusion Medicine, Medical University Vienna, Austria

Chairs:

  • Nicolaus Kröger, MD. Professor of Medicine, Director Department of Stem Cell Transplantation, University Hospital Hamburg-Eppendorf, Hamburg/Germany
  • Christian Chabannon, MD, Ph.D. Head & Qualified person. Centre de Thérapie Cellulaire. Institut Paoli-Calmettes. Comprehensive Cancer Centre & Professor of Medicine in Cell Biology. Aix-Marseille Université School of Medicine Marseille. France
  • Christina Peters, MD. Pediatrician, BMT Unit St. Anna Children’s Hospital, Vienna, Austria

Moderators: 

  • Jörg Halter, MD. Hematology, University Hospital Basel, Switzerland
  • Andreas Buser, MD. Direct of Transfusion Medicine, University Hospital Basel, Switzerland
  • Christina Peters, MD. Pediatrician, BMT Unit St. Anna Children’s Hospital, Vienna, Austria

Speakers: 

  • Nicolaus Kröger, MD. Professor of Medicine, Director Department of Stem Cell Transplantation, University Hospital Hamburg-Eppendorf, Hamburg/Germany
  • Professor Dr. Hildegard T. Greinix. Medical University Graz, Division Head of the Division of Hematology, Austria
  • Miguel Abboud, MD. Physician (pediatrician), Children’s cancer center of Lebanon (CCCL)
  • Volker Witt, MD. Physician (pediatrician), Head of the ICU and apheresis Unit, St. Anna Children’s Hospital, Vienna, Austria.
  • Adriana Balduzzi, MD. Physician (pediatrician), Clinica Pediatrica Universita degli Studi di Milano Biococca, Fondazione MBBM, Monza, Italy
  • Jörg Halter, MD. Hematology, University Hospital Basel, Switzerland.
  • Luca Vago, MD. Unit of Immunogenetics, Leukemia Genomics and Immunobiology, Division of Immunology, Transplantation and Infectious Disease, IRCCS San Raffaele Scientific Institute, Milano, Italy.
  • Michael Pulsipher, MD. Hematology, Oncology and Blood and Marrow Transplantation, Professor of Pediatrics, Keck School of Medicine of USC Children’s Hospital Los Angeles, Los Angeles, USA.
  • Galen Switzer, PhD, Professor of Medicine and Psychiatry. Health services researcher, Psychiatry, and Clinical and Translational Science, Division of General Medicine, University of Pittsburgh, USA.
  • Professor Nina Worel, Medical Director of the collection and processing facility, Department of Transfusion Medicine, Medical University Vienna, Austria

The video and slides are available for EBMT members on the e-learning platform.